Data Suggest Combination Abilities of OP-1250, Palbociclib for Breast Cancer at SABCS
December 9th 2022OP-1250 and palbociclib showed “enhanced suppression of tumor growth” in preclinical mouse model studies, according to expert who presented his findings in a poster at the San Antonio Breast Cancer Symposium 2022.
Read More